Morgan Stanley & Co. Int'l plc Form 8.5 (EPT/RI)-Replacement of Dechra (8810Z)
16 Januar 2024 - 1:50PM
UK Regulatory
TIDMIRSH TIDMDPH
RNS Number : 8810Z
Morgan Stanley & Co. Int'l plc
16 January 2024
AMMENT(2(b))
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH
RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING
CAPACITY
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: Morgan Stanley & Co. International plc
(b) Name of offeror/offeree in relation to whose relevant securities this Dechra Pharmaceuticals plc
form relates:
Use a separate form for each offeror/offeree
----------------------------------------
(c) Name of the party to the offer with which exempt principal trader is EQT (EQT X EUR SCSp and EQT X USD SCSp)
connected:
----------------------------------------
(d) Date dealing undertaken: 05 January 2024
----------------------------------------
(e) In addition to the company in 1(b) above, is the exempt principal N/A
trader making disclosures
in respect of any other party to this offer?
If it is a cash offer or possible cash offer, state "N/A"
----------------------------------------
2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(b), copy
table 2(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of relevant Purchases/ sales Total number of Highest price per unit Lowest price per unit
security securities paid/received paid/received
1p ordinary PURCHASES 229,364 38.6000 GBP 38.5600 GBP
----------------- ------------------------ ----------------------- -----------------------
1p ordinary SALES 9,145 38.6008 GBP 38.5600 GBP
----------------- ------------------------ ----------------------- -----------------------
(b) Cash-settled derivative transactions
Class of relevant Product description Nature of dealing Number of reference Price per unit
security e.g. CFD e.g. opening/closing a securities
long/short position,
increasing/reducing a
long/short position
1p ordinary CFD increasing a short 193,129 38.5600 GBP
position
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD increasing a short 238 38.5800 GBP
position
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD increasing a short 28 38.5800 GBP
position
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD increasing a short 177 38.5800 GBP
position
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD increasing a short 30,087 38.5800 GBP
position
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD increasing a short 1,420 38.5845 GBP
position
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD increasing a short 42 38.5921 GBP
position
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD reducing a long position 2 38.5800 GBP
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD reducing a long position 271 38.5800 GBP
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD reducing a long position 3,370 38.5812 GBP
-------------------- ------------------------- ------------------------- ---------------
1p ordinary CFD reducing a long position 1,167 38.5859 GBP
-------------------- ------------------------- ------------------------- ---------------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class of Product Writing, Number of Exercise Type Expiry date Option money
relevant description purchasing, securities price per e.g. paid/
security e.g. call selling, to which unit American, received per
option varying etc. option European unit
relates etc.
N/A N/A N/A N/A N/A N/A N/A N/A
------------- ------------- ------------- -------------- ------------- ------------ -------------
(ii) Exercise
Class of relevant Product description Exercising/ exercised Number of securities Exercise price per
security e.g. call option against unit
N/A N/A N/A N/A N/A
-------------------- ----------------------- --------------------- -----------------------
(d) Other dealings (including subscribing for new securities)
Class of relevant security Nature of dealing Details Price per unit (if applicable)
e.g. subscription, conversion
N/A N/A N/A N/A
------------------------------- -------- -------------------------------
3. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding, formal
or informal, relating to relevant securities which may be an inducement to deal or refrain
from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between the exempt
principal trader making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
NONE
Date of disclosure: 16 January 2024
Contact name: Craig Horsley
-----------------
Telephone number: +44 141 245-7736
-----------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's dealing disclosure
requirements on +44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk .
, the news service of the London Stock Exchange. RNS is approved by
the Financial Conduct Authority to act as a Primary Information
Provider in the United Kingdom. Terms and conditions relating to
the use and distribution of this information may apply. For further
information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FEREAAFKFLPLEFA
(END) Dow Jones Newswires
January 16, 2024 07:50 ET (12:50 GMT)
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
Von Nov 2024 bis Dez 2024
Dechra Pharmaceuticals (LSE:DPH)
Historical Stock Chart
Von Dez 2023 bis Dez 2024
